ArticleJACC. Case reports2025
Isolating the Superior Vena Cava and Right Atrial Appendage by Pulsed Field Ablation.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pulsed-Field Ablation for Atrial Premature Complexes From the Right Atrial Appendage Apex: A Novel Application.JACC. Case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRight atrial appendage (RAA) isolation using pulsed field ablation (PFA) is a novel approach in atrial fibrillation (AF) management. EARLY REPORT: In the first 2 cases of PFA for acute isolation of the RAA in symptomatic paroxysmal and persistent AF after pulmonary veins isolation and superior vena cava isolation, the RAA isolation led to the cessation of AF and the elimination of premature atrial contractions. The procedure was well-tolerated with no complications or recurrence of AF at 10- and 9-month follow-ups. DISCUSSION: These cases highlight PFA's efficacy in targeting complex arrhythmogenic areas, offering a promising advancement in catheter ablation technology for AF management. These cases show the feasibility of safely isolating the RAA in AF using PFA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.